HCA Healthcare, Inc. $HCA Shares Sold by Darsana Capital Partners LP

Darsana Capital Partners LP reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 20.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,000,000 shares of the company’s stock after selling 250,000 shares during the quarter. HCA Healthcare comprises about 10.9% of Darsana Capital Partners LP’s portfolio, making the stock its 2nd largest position. Darsana Capital Partners LP owned about 0.43% of HCA Healthcare worth $383,100,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in HCA. Norges Bank bought a new stake in HCA Healthcare during the second quarter worth $1,152,408,000. Price T Rowe Associates Inc. MD grew its position in HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Nordea Investment Management AB lifted its holdings in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after acquiring an additional 59,163 shares during the last quarter. LSV Asset Management grew its holdings in shares of HCA Healthcare by 0.4% during the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after purchasing an additional 3,396 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC boosted its position in HCA Healthcare by 29.8% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 795,427 shares of the company’s stock valued at $274,860,000 after buying an additional 182,625 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. KeyCorp raised their price objective on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Cowen reissued a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. TD Cowen lifted their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Finally, Morgan Stanley set a $425.00 target price on HCA Healthcare in a research report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $474.53.

HCA Healthcare Stock Up 2.9%

Shares of NYSE HCA opened at $482.31 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $520.00. The firm has a market cap of $110.06 billion, a PE ratio of 18.64, a P/E/G ratio of 1.38 and a beta of 1.36. The company’s fifty day simple moving average is $464.48 and its 200 day simple moving average is $412.87.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the firm earned $4.90 EPS. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.